Designated Inorganic Nonactive Ingredient Or Elemental Material Other Than Water Patents (Class 514/769)
-
Publication number: 20130330282Abstract: Spray compositions are formulated with powders (e.g. corn starch) which improve skin feel, and also have a hydrophobically modified oxide additive (e.g. modified silica) to reduce the incidence of can/bottle clogging and sedimentation caused by the powder. The oxide is a mixed hydrophobic/hydrophilic oxide such as hydrophobicly modified fumed silica (e.g. silica dimethyl silylate). In one embodiment DEET can be delivered by such formulations.Type: ApplicationFiled: June 8, 2012Publication date: December 12, 2013Inventor: John S. Trent
-
Publication number: 20130316019Abstract: A process is described for the preparation of a stabilized aqueous solution of oxidizing chlorine (anolyte). The process comprises electrolysis of an aqueous solution of sodium chloride or potassium chloride in an electrolytic cell having at least one anode compartment and one cathode compartment separated by a semi-permeable membrane to obtain an anolyte solution in the anode compartment and a catholyte solution in the cathode compartment, and the addition to the anolyte solution produced in this way of a stabilizing agent selected from the group consisting of hydrochloric acid (HCl) of 50 to 250 mg/l, sulphuric acid (H2SO4) of 50 to 350 mg/l, phosphoric acid (H3PO4) of 50 to 500 mg/l, periodic acid (HIO4) of 100 to 1000 mg/l, sodium chloride (NaCl) from 1 to 30 g/l, or any combination thereof. The stabilized anolyte solution produced with the process according to the invention has an advantage of a reduced pH value and increased redox potential value, preferably greater than 960.Type: ApplicationFiled: April 12, 2013Publication date: November 28, 2013Applicant: DUEDI SRLInventors: Cerrato Sergio, D'angelo Domenico, Monti Daniele, Tartaro Daniele, Venturello Alberto
-
Publication number: 20130295180Abstract: A method of preparing a salt product comprises the steps of: (i) providing a mixture which comprises salt dissolved in a solvent, said mixture further containing an organic material that is solid under ambient temperature conditions; and (ii) atomising said mixture and evaporating said solvent to produce a salt product comprised of particles of salt incorporating said organic material. The organic material may be a polymer such as a carbohydrate (e.g. maltodextrin or Gum Arabic). Novel salt products are disclosed which comprise hollow particles having a shell formed for individual crystallites of salt. The salt product is useful as a seasoning for food and may be used in lower amounts than conventional salt to provide the same taste. Particular advantages are obtained in the baking of bread.Type: ApplicationFiled: April 3, 2013Publication date: November 7, 2013Applicant: EMINATE LIMITEDInventors: Stephen John MINTER, Sarah Maude
-
Patent number: 8575223Abstract: A cream has at least two components, one of the components includes stable water clusters, and the cream is applied on a body to produce local surface effects, local deep effects, and non-local effects in the body.Type: GrantFiled: January 28, 2013Date of Patent: November 5, 2013Assignee: D&Y LaboratoriesInventors: Shui Yin Lo, David L. Gann, Martine Gann
-
Publication number: 20130289133Abstract: A method for producing particles containing a metal oxide is provided, and the method includes: feeding a metal oxide sol having a pH of 7 or higher and containing metal oxide colloidal particles as dispersoids and water as a dispersion medium, into a liquid containing a solvent having a solubility in 20° C. water of 0.05 g/100 ml or more and having a relative permittivity of 30 or lower (protic solvent) or of 40 or lower (aprotic solvent) at 20° C., and thereby forming aggregates of the metal oxide colloidal particles in the liquid; and subjecting the aggregates to a treatment such as drying and heating, and thereby converting the aggregates into particles that are insoluble in water. By appropriately selecting the solvent, particles can be obtained in the form of flakes, fibers, spheres, and the like.Type: ApplicationFiled: January 11, 2012Publication date: October 31, 2013Applicant: NIPPON SHEET GLASS COMPANY, LIMITEDInventors: Kazuhiro Doshita, Toshitaka Furuichi
-
Publication number: 20130287820Abstract: Compositions for an oral delivery vehicle are described as well as methods for their manufacture and administration. The oral delivery vehicles can be made in any size or shape and can further comprise a medicament or other substance or object to be orally delivered. The vehicle can, for example, take the form of a pouch or capsule. Alternatively, a medicament or other substance to be orally delivered can be coated with the composition. In another alternative, the medicament or other substance to be orally delivered can be dispersed within a matrix of the composition. The compositions for the oral delivery vehicle are also suitable for use as an animal food or treat or use as a hunting bait or lure.Type: ApplicationFiled: March 19, 2013Publication date: October 31, 2013Inventor: FOODSOURCE LURES CORPORATION
-
Publication number: 20130287817Abstract: A flowable biomedical implant for application to a bone defect to promote bone growth is provided. The flowable biomedical implant comprises a carrier matrix including a biodegradable polysaccharide and ceramic material. An impermeable membrane can be integrally formed at the surface of the carrier matrix by applying a crosslinking agent to the biodegradable polysaccharide mixed with ceramic materials.Type: ApplicationFiled: April 27, 2012Publication date: October 31, 2013Applicant: Warsaw Orthopedic, Inc.Inventors: Susan J. Drapeau, Daniel A. Shimko
-
Publication number: 20130289132Abstract: The invention provides a wavelength converting material comprising a compound of the formula (Y1-w-x-y-zScwLaxGdyLuz)2-a(S04)3:Mea, wherein Me represents trivalent cation or a mixture of trivalent cations capable of emitting UV-C radiation, and wherein each of w, x, y and z is in the range of from 0.0 to 1.0 and w+x+y+z?1.0, and wherein 0.0005?a?0.2. The wavelength converting material may be applied in an illumination device for UV illumination, in particular for sterilization or disinfection by germicidal UV illumination.Type: ApplicationFiled: December 13, 2011Publication date: October 31, 2013Applicant: KONINKLIJKE PHILIPS N.V.Inventors: Georg Greuel, Julian Plewa, Helga Bettentrup, Thomas Juestel
-
Patent number: 8567410Abstract: The present invention relates to aerosols containing magnetic particles, wherein the aerosols comprise magnetic particles and a pharmaceutical active agent. The invention furthermore relates to the use of such aerosols containing magnetic particles for directed magnetic field-guided transfer of the active agents contained therein in aerosol therapy.Type: GrantFiled: August 25, 2006Date of Patent: October 29, 2013Assignee: Ethris GmbHInventors: Carsten Rudolph, Joseph Rosenecker
-
Publication number: 20130274372Abstract: Antimicrobial chemical compositions comprise an aluminum phosphate (AlP) solid dispersed within a binding polymer, wherein one or more bioactive materials are disposed within AlP forming a bioactive-AlP complex. The complex may comprise the bioactive material chemically bonded with the AlP, physically combined with the AlP, or a combination of both. The complex may be formed according to precipitation, condensation and sol-gel methods of forming. The complex is engineered to provide a controlled delivery of the bioactive material or a constituent thereof upon exposure to moisture to give a desired level of antimicrobial resistance to a film or composite formed from the composition of at least about 30 ?g/m2, and may also provide a desired degree of corrosion resistance through the release of passivating phosphate anion.Type: ApplicationFiled: April 16, 2012Publication date: October 17, 2013Applicant: Bunge Amorphic Solutions LLCInventor: Raymond E. Foscante
-
Publication number: 20130267609Abstract: There is provided a gelator that is capable of forming a gel by an extremely small amount of addition in a wide pH range from acidic to alkaline regions, and a gel having high environmental compatibility, biocompatibility, and biodegradability. A gelator comprising: a lipid peptide of Formula (1) wherein R1 is a C9-23 aliphatic group, R2 is a hydrogen atom or a C1-4 alkyl group optionally having a C1-2 branched chain, R3 is a —(CH2)n—X group, n is a number from 1 to 4, and X is an amino group, a guanidino group, a —CONH2 group, or a 5-membered ring optionally having 1 to 3 nitrogen atoms, a 6-membered ring optionally having 1 to 3 nitrogen atoms, or a fused heterocycle including a 5-membered ring and a 6-membered ring that optionally has 1 to 3 nitrogen atoms); or a pharmaceutically usable salt of the lipid peptide.Type: ApplicationFiled: June 6, 2013Publication date: October 10, 2013Applicant: Nissan Chemical Industries, Ltd.Inventors: Misao MIYAMOTO, Nobuhide MIYACHI, Takehisa IWAMA
-
Publication number: 20130267610Abstract: There is provided a gelator that is capable of forming a gel by an extremely small amount of addition in a wide pH range from acidic to alkaline regions, and a gel having high environmental compatibility, biocompatibility, and biodegradability. A gelator comprising: a lipid peptide of Formula (1) wherein R1 is a C9-23 aliphatic group, R2 is a hydrogen atom or a C1-4 alkyl group optionally having a C1-2 branched chain, R3 is a —(CH2)n—X group, n is a number from 1 to 4, and X is an amino group, a guanidino group, a —CONH2 group, or a 5-membered ring optionally having 1 to 3 nitrogen atoms, a 6-membered ring optionally having 1 to 3 nitrogen atoms, or a fused heterocycle including a 5-membered ring and a 6-membered ring that optionally has 1 to 3 nitrogen atoms); or a pharmaceutically usable salt of the lipid peptide.Type: ApplicationFiled: June 6, 2013Publication date: October 10, 2013Applicant: Nissan Chemical Industries, Ltd.Inventors: Misao MIYAMOTO, Nobuhide MIYACHI, Takehisa IWAMA
-
Publication number: 20130259582Abstract: A soil adherent pellet is detailed that includes a soluble calcium ion source, a magnesium ion source, or both present in an amount ranging from 15% to 99.9% by weight of a total dry weight of the pellet and a binder present in an amount ranging from 85% to 0.1% by weight of the total dry weight of the pellet. The pellet having a mean pellet domain size and a pellet surface. The soil adherent pellet is well suited for flocculating clay within the soil and delivery of an active ingredient with reduced runoff compared to prior art broadcast particles. A soil adherent pellet is also provided having a soluble calcium and/or magnesium ion source that is polycrystalline and carries therewith an active ingredient.Type: ApplicationFiled: April 1, 2013Publication date: October 3, 2013Applicant: The Andersons, Inc.Inventors: Timothy D. Birthisel, Joseph Schalk, Joseph Schanski
-
Patent number: 8546334Abstract: The present invention relates to a device having osteoinductive and osteoconductive properties in vivo comprising a carrier containing calcium phosphate and an osteoinductive protein, wherein the carrier is homogenously coated with the protein. Moreover, the present invention relates to a method for the production of a device having osteoinductive and osteoconductive properties in vivo. The invention encompasses a pharmaceutical composition comprising the device of the invention or a device which is obtainable by the method of the invention and relates to the use of the device for the preparation of a pharmaceutical composition to be used for bone augmentation, for treating bone defects, for treating degenerative and traumatic disc disease, for treating bone dehiscence or to be used for sinus floor elevation. Finally, the invention relates to a kit comprising the device of the invention or a device which is obtainable by the method of the invention.Type: GrantFiled: March 27, 2002Date of Patent: October 1, 2013Assignee: Scil Technology GmbHInventors: Ulrich Kohnert, Sylke Pohling, Klaus Hellerbrand, Peter Happersberger
-
Publication number: 20130253014Abstract: Described herein are cyclodextrin-stabilized microemulsion systems useful for increasing the solubility, stability, bioavailability, or safety of an active agent for delivery to the skin. The microemulsions may reduce the occurrence of skin irritation or odor upon application.Type: ApplicationFiled: March 14, 2013Publication date: September 26, 2013Applicant: Precision Dermatology, Inc.Inventors: Mark W. Trumbore, Pinaki Ranjan Majhi, Dinen Divyang Shah
-
Publication number: 20130253015Abstract: Described herein are cyclodextrin-stabilized microemulsion systems useful for increasing the solubility, stability, bioavailability, or safety of an active agent for delivery to the skin. The microemulsions may reduce the occurrence of skin irritation or odor upon application. In certain embodiments, the active agent is substantially insoluble in water.Type: ApplicationFiled: March 14, 2013Publication date: September 26, 2013Applicant: Precision Dermatology, Inc.Inventors: Pinaki Ranjan Majhi, Mark W. Trumbore
-
Publication number: 20130251818Abstract: Personal lubricants containing royal jelly, a glow powder or xylitol are provided.Type: ApplicationFiled: March 22, 2013Publication date: September 26, 2013Applicant: Nature Labs USA LLCInventors: Louis J. Rivers, IV, Kevin Stranen
-
Publication number: 20130251644Abstract: Described herein are cyclodextrin-stabilized microemulsion systems useful for increasing the solubility, stability, bioavailability, or safety of an active agent for delivery to the skin. The microemulsions may reduce the occurrence of skin irritation or odor upon application. In certain embodiments, the active agent is substantially insoluble in water. The microemulsions may be formulated as semi-solids, for example creams, or as aerosol or non-aerosol foams. Also described are methods of treating skin disorders, comprising the step of applying to an affected area of a subject in need thereof a therapeutically-effective amount of an inventive microemulsion.Type: ApplicationFiled: March 14, 2013Publication date: September 26, 2013Applicant: Precision Dermatology, Inc.Inventors: Pinaki Ranjan Majhi, Mark W. Trumbore
-
Patent number: 8536230Abstract: The present invention provides a method for preparing chitosan solutions to allow regulating the conditions in which the chitosan solution will gel. The present invention also provides methods for using chitosan solutions as compositions and for using chitosan solutions in vitro and in vivo.Type: GrantFiled: January 25, 2007Date of Patent: September 17, 2013Assignee: University of Virginia Patent FoundationInventors: Cato T. Laurencin, Lakshmi Sreedharan Nair
-
Publication number: 20130236513Abstract: Embodiments of the present inventions comprise composites of polyurethane(s), osteoconductive matrix, and, optionally, a growth factor. Embodiments further comprise methods of making such composite and uses thereof. The osteoconductive matrix can be a tricalcium phosphate, bioglass, or the like, and can include particles that are surface modified. Growth factors can be provided in powder form, including bone morphogenic proteins such as rhBMP-2. A composition may be moldable and/or injectable. After implantation or injection, a composition may be set to form a porous composite that provides mechanical strength and supports the in-growth of cells.Type: ApplicationFiled: April 22, 2013Publication date: September 12, 2013Applicant: Vanderbilt UniversityInventors: Scott A. Guelcher, Jerald Dumas, Edna M. Prieto, Kerem Kalpakci, Anne Talley, Andrew Harmata, Katarzyna Zienkiewicz
-
Publication number: 20130224261Abstract: Environmentally-responsive composites useful for intracellular delivery of therapeutic agents.Type: ApplicationFiled: February 19, 2013Publication date: August 29, 2013Applicant: University of Washington Through Its Center For CommercializationInventor: University of Washington Through Its Center For Commercialization
-
Patent number: 8519010Abstract: What is described herein are antimicrobial compositions which are defined blends of a 1,2-diol and phenoxyethanol which show broad activity against bacteria, fungi and mold spores. This activity is potentiated by the addition thereto of small amounts of a co-biocide for which the blend acts as a delivery system for the otherwise water-insoluble co-biocide.Type: GrantFiled: April 29, 2011Date of Patent: August 27, 2013Assignee: ISP Investments Inc.Inventors: John J. Merianos, Paul Garelick, Susan M. Lindstrom
-
Publication number: 20130217785Abstract: An animal feed compact is provided by the present disclosure that includes a body having a various feed composition and an adhesive additive. The adhesive additive includes a starch and a hydroxide. Further additives may also be provided, which include any edible/digestible alfalfa meal, sunflower meal grain, ruffage [roughage], soybean meal wheat mids, hay, stover, whey dicalcium phosphate, limestone molasses, minerals, vitamins and medication. Various geometries and compositions for the biomass fuel compact are also provided by the present disclosure.Type: ApplicationFiled: March 15, 2013Publication date: August 22, 2013Applicant: Enginuity Worldwide, LLCInventor: Enginuity Worldwide, LLC
-
Publication number: 20130213398Abstract: The present invention is directed toward respirable dry particles for delivery of divalent metal cation salts and/or monovalent cation salts to the respiratory tract and methods for treating a subject having a respiratory disease and/or infection.Type: ApplicationFiled: August 26, 2011Publication date: August 22, 2013Inventors: Michael M. Lipp, Jean C. Sung, Robert W. Clarke, David L. Hava
-
Publication number: 20130203862Abstract: Methods for solubilizing carbon nanohorns and applications thereof, including the manufacture of composites, hydrogen storage, catalyst supports and drug delivery. In certain embodiments, the method can include: a) Reduction of pristine carbon nanohorns by an alkali metal to lead to a carbon nanohorn alkali salt; and b) Exposure of said carbon nanohorn alkali salt to a polar aprotic solvent to lead to a solution of reduced carbon nanohorns. In certain other embodiments, solutions of carbon nanohorns, and individual carbon nanohorns are obtainable by the methods, as well as uses of such individual carbon nanohorns and solutions of carbon nanohorns.Type: ApplicationFiled: June 7, 2011Publication date: August 8, 2013Applicant: Centre National de la Recherche Scientifique -CNRSInventors: Alain Penicaud, Damien Voiry, Nikos Tagmatarchis, Georgia Pagona
-
Publication number: 20130197035Abstract: Disclosed herein are surgical adjuvant compositions for ameliorating tissue and cellular necrosis and/or apoptosis. In addition, surgical methods are described which include the use of the adjuvant of the composition to reduce tissue and cellular necrosis and/or apoptosis.Type: ApplicationFiled: March 12, 2013Publication date: August 1, 2013Inventors: Ian K.Y. Lo, Paul Sciore, Ken Muldrew
-
Publication number: 20130172374Abstract: A novel solid composition and methods for making and using the solid composition are provided. The solid composition comprises: (a) at least one active agent with a solubility of less than about 0.3 mg/ml in an aqueous solution with a pH of at most about 6.8 at a temperature of about 37° C.; and (b) a hydrophilic polymer matrix composition comprising: i) a hydrophilic polymer selected from the group consisting of METHOCEL™, POLYOX™ WSR 1105 and combinations thereof; and optionally ii) a hydrophobic polymer selected from the group consisting of Ethocel 20 premium; and (c) an alkalizer selected from the group consisting of calcium carbonate, magnesium oxide heavy and sodium bicarbonate; wherein the composition provides at least about 70% release of the active between about 7 to about 12 hours following oral administration.Type: ApplicationFiled: October 1, 2012Publication date: July 4, 2013Applicant: Portola Pharmaceuticals, Inc.Inventor: Portola Pharmaceuticals, Inc.
-
Publication number: 20130172357Abstract: The invention provides ?-2 adrenergic receptor agonist compositions and methods for treating glaucoma and other intraocular conditions. The preferred ?-2 agonist used in the inventive compositions and methods is dexmedetomidine.Type: ApplicationFiled: February 5, 2013Publication date: July 4, 2013Applicant: EYE THERAPIES LLCInventor: Eye Therapies LLC
-
Publication number: 20130164335Abstract: Methods and compositions for producing a cellular drug release are disclosed. The method comprises: a) providing a composition comprising a therapeutically effective amount of a pharmacological agent adsorbed onto mesoporous hydroxyapatite (HAP) with hydrophobic surfaces; b) exposing the composition to a cell; c) causing entry of the mesoporous HAP into the cell and degradation of the HAP in the lysosomes of the cell and desorption of the agent from the mesoporous HAP; d) causing release of the desorbed agent from the lysosomes into the cytoplasm of the cell; and e) causing release of the desorbed agent to outside the cell. The composition comprises a) mesoporous HAP with hydrophobic surfaces; and b) a therapeutically effective amount of a pharmacological agent, adsorbed onto the hydrophobic surfaces of the mesoporous. HAP. The composition is characterized in that it constantly releases the agent in vivo for a period of at least 4 weeks.Type: ApplicationFiled: December 27, 2011Publication date: June 27, 2013Applicant: NATIONAL HEALTH RESEARCH INSTITUTESInventors: Cheng CHEN, Feng-Huei Lin
-
Publication number: 20130165531Abstract: The invention describes novel aluminum based aqueous anthocyanin solutions, methods to prepare them and the compositions thereof.Type: ApplicationFiled: June 12, 2012Publication date: June 27, 2013Applicant: E.P.C. (Beijing) Plant Pharmaceutical Technology Co., Ltd.Inventors: Jingang Shi, Hui Ma, Zhijin Jin
-
Publication number: 20130164354Abstract: Disclosed is a method for the preparation of cosmetic compositions having the texture of a cream. Said preparation is made at the time when the composition is used and includes bringing into contact with each other (A) a liquid phase, (B) a powder containing a gelling agent for the liquid phase (A), and (C) an active cosmetic ingredient, whereby the elements are brought into contact by adding phase (A) to phase (B), subjecting a solid powder containing phase (B) and phase (A) in an immobilized form to mechanical stress to release phase (A). Further disclosed are compositions comprising phase (B) and phase (A) in an immobilized form which are transformed into a cream when applied to the skin).Type: ApplicationFiled: July 10, 2012Publication date: June 27, 2013Inventors: Martine Seu-Salerno, Laurence Fillardet, Virginie Boulier
-
Publication number: 20130156871Abstract: A composition provides an isotonic nasal irrigation solution with pH less than about 7.0. The composition may be formed of a salt and a pH buffer and may include an additive. The composition may be mixed with water to form the solution. The composition may aid in the treatment of various nasal or sinus disorders such as, for example, dryness, rhinitis, and sinusitis. The isotonic irrigation solution may also aid in the removal of contaminants from the sinus and nasal cavities such as blood, mucus, dirt, pollen, allergens, viruses, and bacterial. The composition may be liquid or dry.Type: ApplicationFiled: December 20, 2012Publication date: June 20, 2013Applicant: WATER PIK, INC.Inventor: Water Pik, Inc.
-
Publication number: 20130150313Abstract: A malleable compound according to the invention for use as a disinfectant comprises water, 25 to 40% by weight of a solvent component comprising low-molecular, water-miscible alcohols, 1 to 10% by weight of an active bactericidal component, 3 to 6% by weight hydroxypropylated polygalactomannan with an etherification level of between 0.3 and 1.5 and 0.1 to 0.5% by weight boracic acid or an equivalent amount of boron ions.Type: ApplicationFiled: March 16, 2011Publication date: June 13, 2013Applicant: JOKER AGInventors: Meinrad Flury, Rene H. Dietrich
-
Publication number: 20130137670Abstract: A formulation is provided that includes a volume of an aqueous multivalent physiological ion solution compatible with cerebrospinal fluid containing at least one divalent cation of magnesium or calcium, and at least one anion of carbonate or phosphate, and having a pH between 6.5 and 8.0. A zwitterionic therapeutic agent other than baclofen is dissolved the solution to achieve higher concentration or ease of solution and/or storage relative to therapeutic saline solutions of the same agent. A process of delivering a zwitterionic therapeutic agent into a subject is provided that includes dissolving a therapeutic amount of the zwitterionic therapeutic agent in a volume of artificial cerebrospinal fluid to form a stable formulation. The solution is then administered to the subject using an intrathecal pump.Type: ApplicationFiled: January 25, 2013Publication date: May 30, 2013Applicant: WAYNE STATE UNIVERSITY BOARD OF GOVERNORSInventor: Wayne State University Board of Governors
-
Patent number: 8449868Abstract: The present invention is directed to cationic nanoparticles, methods to make them, and the use of compositions containing said nanoparticles in personal care compositions or formulations. The nanoparticles are useful in personal care applications and impart antimicrobial properties to home and personal care products containing them. These cationic nanoparticles also contribute useful conditioning properties to hair-care and skin-care products.Type: GrantFiled: February 17, 2009Date of Patent: May 28, 2013Assignee: BASF SEInventors: John Jennings, Dietmar Hüglin, Jianwen Mao, Andreas Mühlebach
-
Publication number: 20130122467Abstract: Disclosed herein are compositions that can rapidly evolve oxygen and/or activated oxygen generally including an oxidizing agent (e.g., a peroxide) and an activating agent that has an emission wavelength between about 400 nm and about 570 nm (e.g., Eosin B, Eosin Y, or Erythrosine B). Methods of employing these compositions to whiten teeth, and methods of making these compositions and kits that include some or part of the composition ingredients, are also described.Type: ApplicationFiled: April 29, 2011Publication date: May 16, 2013Applicant: KLOX Technologies Inc.Inventors: Remigio Piergallini, Nikolaos Loupis
-
Publication number: 20130116338Abstract: A nanometal dispersion and a method for preparing a nanometal dispersion are provided. The method comprises the following steps: providing a first solution containing a metal ion; providing a second solution containing inulin; mixing the first solution and the second solution to provide a third solution; and providing energy to the third solution to conduct a reduction-oxidation reaction to form a nanometal therein. The produced nanometal dispersion comprises inulin and a nanometal with multimorphology.Type: ApplicationFiled: November 4, 2011Publication date: May 9, 2013Applicant: CHINA MEDICAL UNIVERSITYInventors: Chih-Wei CHOU, Ya-Hsun HOU, Yueh-Hsiung KUO, Yung-Hsiu CHEN
-
Publication number: 20130115268Abstract: Methods for administering a dermatological agent to a subject are provided. In the subject methods an effective amount of a topical formulation of the dermatological agent is topically applied to a host. The topically applied formulation of dermatological agent is then occluded with a hydrogel patch, where a feature of the hydrogel patch is that it lacks a pharmaceutically active agent. Also provided are methods of treating a subject for a disease condition by administering a dermatological agent to the subject. Also provided are kits for use in practicing the subject methods. The subject methods and compositions find use in a variety of different applications.Type: ApplicationFiled: December 27, 2012Publication date: May 9, 2013Applicants: TEIKIKOKU SEIYAKU KABUSHIKI KAISHA, TEIKOKU PHARMA USA, INC.Inventors: Teikoku Pharma USA, INC., Teikikoku Seiyaku Kabushiki Kaisha
-
Patent number: 8435496Abstract: A method for providing nanoparticle clusters of controlled dimensions is described. The method involves an activation of individual nanoparticles and the subsequent interaction between activated particles to form a cluster.Type: GrantFiled: December 12, 2007Date of Patent: May 7, 2013Assignee: Dublin City UniversityInventors: Dermot Brougham, Swapankumar Ghosh
-
Patent number: 8431587Abstract: The invention is based on the surprising finding that treatment with a chemotherapeutic agent such as 5-fluorouracil (5-FU) and an autophagy inducer effectively inhibit the continued growth of, and prevent the recovery following drug withdrawal, of cancer cells. In vivo, drug resistance from a failure to adequately engage in apoptotic programmed cell death leads to a recurrence of cancer and tumours can remain dormant for periods of time before re-emerging as drug resistant metastases. It has been hypothesised that autophagy (Type II cell death) may help cancer cells survive in response to growth limiting conditions, such as nutrient depletion, hypoxia, absence of growth factor, or presence of cytotoxic drug. LiCl is a known autophagy inducer and accelerates cell survival to autophagic programmed cell death.Type: GrantFiled: July 15, 2010Date of Patent: April 30, 2013Assignee: University College Cork, National University of Ireland, CorkInventors: Sharon McKenna, Gerald C. O'Sullivan, Tracey O'Donovan
-
Publication number: 20130101684Abstract: The present invention provides edible compositions comprising a compound of the present invention, food products comprising such edible compositions and methods of preparing such food products. The present invention also provides methods of reducing the amount of NaCl in a food product, methods of reducing the sodium intake in a diet, and methods of reducing bitter taste in a food product.Type: ApplicationFiled: April 15, 2011Publication date: April 25, 2013Applicant: Chromocell CorporationInventors: Jane V. Leland, Louise Slade, David Hayashi, William P. Jones, Peter H. Brown, Joseph Gunnet, Daniel Lavery, Jessica Langer, Kambiz Shekdar
-
Publication number: 20130099410Abstract: Provided are cap layer compositions and base layer compositions, providing quick and extended release of an active ingredient, respectively, when placed in water. Further provided are dual release compositions including a base composition and a cap composition. The base composition may include a plaster and an active agent, and it may further include at least one of a water-soluble binder, a non-water-soluble binder, and a lubricant. The cap composition may include a plaster and an active agent, and it may further include at least one of a disintegrating agent, a non-water-soluble binder, and a lubricant. The compositions may be heated and mixed and formed into a tablet. Further provided are methods of making the compositions. Further provided are methods of controlling or eliminating pests and methods of increasing the potability of water. The compositions are effective for controlling or eliminating pests such as mosquitoes when applied at an application site.Type: ApplicationFiled: December 10, 2012Publication date: April 25, 2013Applicant: CLARKE MOSQUITO CONTROL PRODUCTS, INC.Inventor: Clarke Mosquito Control Products, Inc.
-
Publication number: 20130095147Abstract: A bioactive sol-gel solution includes a biocompatible polymer, a gelable inorganic base material, and at least one calcium and phosphorous molecular species. The base material can be an alkoxide, such as TEOS. The polymer acts as a viscosity modifier to the sol or gel, increases the viscosity range over which fibers can be sprayed or spun, and broadens the time period over which fibers can be sprayed or spun. A bioactive glass composite can be formed from the bioactive sol-gel solution, including a fibrous form. Fibers can serve as a scaffolds for cell growth and in the repair of hard or soft tissue defects.Type: ApplicationFiled: November 30, 2012Publication date: April 18, 2013Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.Inventor: University of Florida Research Foundation, Inc.
-
Publication number: 20130096205Abstract: Provided is an aqueous composition contained in a container, maintaining an excellent water-evaporation-inhibiting effect even when an alkali metal salt or the like is contained in the aqueous composition, and having excellent long-term stability. The aqueous composition contained in a container includes the following components (A) to (D): (A) a polyoxyethylene alkyl or alkenyl ether having an alkyl or alkenyl group having 20 to 24 carbon atoms and an average molar number of ethylene oxide added of 1.5 to 4, (B) a water-soluble polymer, (C) a nonionic surfactant having an ethylene oxide group (but excluding component (A)), and (D) water.Type: ApplicationFiled: May 26, 2011Publication date: April 18, 2013Applicant: KAO CORPORATIONInventor: Takeshi Murata
-
Publication number: 20130089585Abstract: The present invention pertains to a filler comprising beads wherein said beads comprise a polyanionic biopolymer and divalent cations and wherein said polyanionic biopolymer is not alginate. Further, the present invention pertains to a process for manufacturing the claimed filler, and to an injection device comprising the filler.Type: ApplicationFiled: April 7, 2011Publication date: April 11, 2013Applicant: MERZ PHARMA GmbH & CO., KGaAInventors: Kevin Kiehm, Bernhard Hauptmeier, Peter Boderke
-
Publication number: 20130090387Abstract: Citric acid and conjugate bases thereof are useful for stabilizing stabilized chlorine dioxide in the presence of therapeutically active agents and excipients in a composition. Ophthalmic compositions and methods related thereto are also disclosed herein.Type: ApplicationFiled: November 30, 2012Publication date: April 11, 2013Applicant: Allergan, Inc.Inventor: Allergan, Inc.
-
Publication number: 20130079228Abstract: An agrichemical is disclosed having increased bio-activity which is adapted for spray application in a form which offers reduced aerial drift and improved deposition on organisms, reduced agglomeration and gellation problems, is adapted for use with chemicals, pesticides and fertilizers and allows for lower agrichemical use rates. Various adjuvants and surfactants are combined with fertilizers or pesticides, such as herbicides fungicides and insecticides, to reduce application problems relating to droplet size, foaming, chemical stability, plant and area coverage, droplet drift, surface tension, suspension, incompatability, phytoxicity, solubility, volatilization and evaporation, while providing enhanced bio-efficacy and low aquatic toxicity. Purifying the agrichemical composition water source by any of various known processes such as oxidation, ultra-filtration, deionization, reverse osmosis or nanofiltration lowers or removes alkaline components, such as calcium, magnesium, iron, sodium, etc.Type: ApplicationFiled: September 23, 2011Publication date: March 28, 2013Inventor: Brian E. Freed
-
Publication number: 20130078282Abstract: Formulations have been developed for pulmonary delivery to treat or reduce the infectivity of diseases such as viral infections, especially tuberculosis, SARS, influenza and respiratory synticial virus in humans and hoof and mouth disease in animals, or to reduce the symptoms of allergy or other pulmonary disease. Formulations for pulmonary administration include a material that significantly alters physical properties such as surface tension and surface elasticity of lung mucus lining fluid, which may be isotonic saline and, optionally, a carrier. The formulation may be administered as a liquid solution, suspension, aerosol, or powder where the particles consist basically of an osmotically active solute. Drugs, especially antivirals or antibiotics, may optionally be included with the formulation. These may be administered with or incorporated into the formulation.Type: ApplicationFiled: April 25, 2012Publication date: March 28, 2013Applicant: Pulmatrix, Inc.Inventors: David A. Edwards, Jonathan C. Man, Jeffrey P. Katstra, Robert W. Clarke
-
Patent number: 8404255Abstract: In the preferred embodiment, the invention is a system for creating micropores in the skin for transdermal drug delivery through the micropores and includes: a chemical that dissolves or breaks down superficial layers of skin; a chemical delivery element that holds and delivers controlled volumes of the chemical to skin, creating micropores; and a base that is able to temporarily couple to skin, contains the chemical delivery elements, and may activate the chemical delivery elements to administer the chemical to skin. In the preferred embodiment, the invention is a method for delivering drugs transdermally that includes providing a carrier containing a chemical delivery element with a chemical to break down superficial layers of skin; placing the carrier into contact with skin; activating the chemical delivery element; allowing the chemical to break down superficial layers of skin and creating micropores; and providing a drug to be delivered transdermally through the micropores.Type: GrantFiled: December 12, 2008Date of Patent: March 26, 2013Inventors: Matt Gibson, Takashi Yoshida Kozai, Erin Purcell
-
Publication number: 20130065885Abstract: The present invention relates generally to therapeutic formulations. More particularly, this present invention provides an oral delivery system for a therapeutic compound that is a base, a salt of a base or an amphoteric compound or a salt of a amphoteric compound with pharmacological, physiological or biochemical activity or a proactive form thereof. The present invention even more particularly provides a swallow formulation comprising a therapeutic compound that is a base, a salt of a base, an amphoteric compound or a salt of an amphoteric compound which facilitates the rapid delivery of the therapeutic compound to the circulatory system.Type: ApplicationFiled: September 14, 2012Publication date: March 14, 2013Applicant: IMAGINOT PTY LTD.Inventors: Michael Stephen Roberts, Ruoying Jiang, Keivan Bezanehtak, Greg Andrew Davey, George Alexander Davidson, Geraldine Ann Elliott, Stephen Douglas Chandler, Mantu Sarkar